Ciba-Geigy Limited Commences Tender Offer for Chiron Corp.

Strategic Insights -

Ciba-Geigy Limited, through a wholly owned subsidiary, has commenced a tender offer to purchase 11,860,467 shares of Chiron Corp.'s common stock, representing approximately 37.3% of Chiron's outstanding shares. The offer is conditioned upon the tender of 11,860,467 shares, regulatory approvals, and the satisfaction of conditions related to Ciba's contribution of its Ciba Corning Diagnostics business and interests in joint vaccine businesses to Chiron in exchange for 6.6 million shares of Chiron common stock. The offer is being made pursuant to an Investment Agreement, which will form a strategic partnership between Ciba and Chiron.

Key Takeaways:

  • The tender offer represents a significant stake in Chiron Corp., with Ciba-Geigy Limited acquiring approximately 37.3% of Chiron's outstanding shares.
  • The offer is conditioned upon the tender of 11,860,467 shares, regulatory approvals, and the satisfaction of conditions related to Ciba's contribution of its Ciba Corning Diagnostics business and interests in joint vaccine businesses to Chiron.
  • Ciba's Pharmaceuticals Division has branches, joint ventures, scientific offices, and agencies in over 190 countries, with 1993 sales of SFr. 6,599 million ($4,459 million).
  • The Investment Agreement will form a strategic partnership between Ciba and Chiron, with Morgan Stanley & Co. Inc. and Robertson Stephens, & Co. acting as financial advisers to Chiron.
  • The board of directors of Chiron has approved the offer, the shares issuance, and the other transactions described in the Investment Agreement, determining that the terms are fair to and in the best interest of Chiron's stockholders.

Statistics:

  • 11,860,467 shares of Chiron Corp.'s common stock are being offered for purchase.
  • The offer represents approximately 37.3% of Chiron's outstanding shares.
  • The consideration to be received by Chiron stockholders is $117.00 per share.
  • Ciba-Geigy Limited's 1993 sales were SFr. 22,647 million ($15,302 million).
  • Ciba's Pharmaceuticals Division has 1993 sales of SFr. 6,599 million ($4,459 million).

Sources:

  • BUSINESS WIRE: CIBA-GEIGY Announces Tender Offer for Chiron Corp. - November 28, 1994
  • CIBA-GEIGY Limited, Ciba Corporation, and Chiron Corporation official reports and press releases cited in the original source.